作者: Forage飼料 時(shí)間: 2025-3-21 20:34 作者: Capture 時(shí)間: 2025-3-22 01:42 作者: 合同 時(shí)間: 2025-3-22 04:45
Obstructive and Central Sleep Apnea Treatment Challenges in Atrial Fibrillation,besity epidemic are likely explanatory factors of the increase in incidence of AF, but still a proportion of the risk remains unexplained. Sleep apnea is a likely promoter of this trend. As the prevalence of obstructive sleep apnea (OSA) is increasing in concert with increasing recognition based upo作者: grovel 時(shí)間: 2025-3-22 12:20 作者: ASTER 時(shí)間: 2025-3-22 16:28
Pulmonary Hypertension in Obstructive Sleep Apnea,gher. Mild pulmonary arterial hypertension may occur in patients with OSA without daytime hypoxemia or chronic obstructive pulmonary disease. However, pulmonary hypertension could be more severe in the presence of chronic lung disease, heart failure, and obesity hypoventilation. Studies, mostly obse作者: ASTER 時(shí)間: 2025-3-22 20:16 作者: 印第安人 時(shí)間: 2025-3-22 23:42 作者: 可轉(zhuǎn)變 時(shí)間: 2025-3-23 04:30
Upper Airway Resistance Syndrome,ographic findings of prolonged inspiratory flow limitation and repeated arousals from sleep due to increased upper airway resistive events that do not meet the criteria for apneas or hypopneas. While now subsumed under the diagnosis of obstructive sleep apnea as a clinical entity, the term remains i作者: 惰性女人 時(shí)間: 2025-3-23 08:00 作者: craven 時(shí)間: 2025-3-23 12:10 作者: 帽子 時(shí)間: 2025-3-23 17:10 作者: 羽毛長(zhǎng)成 時(shí)間: 2025-3-23 18:14 作者: Facilities 時(shí)間: 2025-3-24 02:04 作者: SIT 時(shí)間: 2025-3-24 03:43
Postoperative Respiratory Failure,e incidence of PRF in the general surgical population ranges from 0.2% to 3.4%, with a mortality rate that in certain cases can exceed 25%. Several predictive scores have been validated to identify at risk patient populations. These scores are driven by preexisting patient factors, comorbid conditio作者: Endemic 時(shí)間: 2025-3-24 10:15 作者: SUGAR 時(shí)間: 2025-3-24 11:10 作者: Veneer 時(shí)間: 2025-3-24 15:45 作者: amnesia 時(shí)間: 2025-3-24 22:24
Treatment-Emergent Central Sleep Apnea,poor adherence and CPAP use termination with ongoing poor quality of life and symptoms. This can be addressed by tailoring therapy early with treatments such as adaptive servo-ventilation. Because of the multifactorial nature of TE-CSA pathogenesis, optimal treatment may require multi-modality thera作者: Living-Will 時(shí)間: 2025-3-25 00:50
Sleep Apnea in Pregnancy,ell as more severe outcomes including cardiomyopathy, congestive heart failure, need for postpartum hysterectomy, and even death. Infants of women with sleep apnea have a higher risk of low birthweight, preterm delivery, and small for gestational age. Positive airway pressure therapy (e.g., CPAP) is作者: Debility 時(shí)間: 2025-3-25 06:44 作者: Occipital-Lobe 時(shí)間: 2025-3-25 08:00 作者: scrutiny 時(shí)間: 2025-3-25 12:57 作者: 不可救藥 時(shí)間: 2025-3-25 16:28
sebook of Challenging Patients is a necessary resource for all sleep trainees and pulmonary fellows, as well as a resource for sleep specialists including sleep technicians.?.978-3-030-57941-8978-3-030-57942-5作者: 氣候 時(shí)間: 2025-3-25 22:38
Congenital Central Hypoventilation Syndrome (CCHS),作者: 分發(fā) 時(shí)間: 2025-3-26 04:12 作者: ABYSS 時(shí)間: 2025-3-26 06:43 作者: FAWN 時(shí)間: 2025-3-26 08:39
Staffeltarife und Wasserstrassenell as more severe outcomes including cardiomyopathy, congestive heart failure, need for postpartum hysterectomy, and even death. Infants of women with sleep apnea have a higher risk of low birthweight, preterm delivery, and small for gestational age. Positive airway pressure therapy (e.g., CPAP) is作者: 加強(qiáng)防衛(wèi) 時(shí)間: 2025-3-26 13:23 作者: 一條卷發(fā) 時(shí)間: 2025-3-26 18:25 作者: champaign 時(shí)間: 2025-3-27 00:02 作者: 業(yè)余愛(ài)好者 時(shí)間: 2025-3-27 01:13 作者: 上坡 時(shí)間: 2025-3-27 06:33 作者: Lice692 時(shí)間: 2025-3-27 11:18
https://doi.org/10.1007/978-3-642-55434-6al, or both. Understanding the assessment, diagnosis, and treatment of patients with potential sleep-disordered breathing is essential for appropriate management of patients post-stroke. A case of a patient with both obstructive and central sleep apnea after a stroke is reviewed as an example of the作者: 厚臉皮 時(shí)間: 2025-3-27 16:36 作者: GRIPE 時(shí)間: 2025-3-27 20:22
Gerhard Hammerschmid,Renate Meyers a worse prognosis for the patient. Sleep breathing disorders in preserved ejection fraction or diastolic dysfunction are less well described. Treatment options include CPAP, supplemental oxygen, and adaptive servo-ventilation. These therapies often do well to control the AHI, though some remain re作者: 發(fā)微光 時(shí)間: 2025-3-28 01:43 作者: 平 時(shí)間: 2025-3-28 02:08
David Farnham,Annie Hondeghem,Sylvia Hortonsent or decreased inspiratory effort due to decreased central neural input to the respiratory motor neurons. Primary central sleep apnea is a diagnosis of exclusion—heart failure, neuromuscular disease, medications, opioids, and central disorders like stroke or brain tumors must be excluded. Primary作者: capsaicin 時(shí)間: 2025-3-28 10:04
David Farnham,Annie Hondeghem,Sylvia Hortony in individuals with obstructive sleep apnea (OSA). It is a non-rapid eye movement sleep process, driven by an overly sensitive ventilatory control system and sleep-wake instability superimposed on increased upper airway collapsibility. TE-CSA affects roughly 5–10% of OSA patients treated with cont作者: Meander 時(shí)間: 2025-3-28 10:56 作者: Mammal 時(shí)間: 2025-3-28 18:24 作者: muffler 時(shí)間: 2025-3-28 18:48
Theatrical Compressions of Time and Space,ide retention. Most patients have obstructive sleep apnea and may develop cor pulmonale. The pathophysiology is complex and includes excessive load on the respiratory system, altered ventilator control, and functional respiratory impairment. Screening for OHS should include elevated serum bicarbonat作者: filial 時(shí)間: 2025-3-28 23:09 作者: 惡意 時(shí)間: 2025-3-29 04:35
The Designer as Global Cartographer,ern that adherence would be low and that quality of life may be compromised. However, home non-invasive ventilation can be effective in COPD with persistent hypercapnia (PaCO.?>?52?mmHg) while in a stable state. Device settings are equally important, as recent randomized trials have found significan作者: persistence 時(shí)間: 2025-3-29 07:56
https://doi.org/10.1057/9781137108395ange during sleep and may present with headache and daytime fatigue. Polysomnographic findings may show hypercapnia and hypoxemia, which are most pronounced in rapid eye movement sleep. Noninvasive positive pressure ventilation (NIPPV) is an effective treatment. Clinicians should be aware of the rat作者: deadlock 時(shí)間: 2025-3-29 11:59
Michael Frayn: Dust and Scaffoldinge incidence of PRF in the general surgical population ranges from 0.2% to 3.4%, with a mortality rate that in certain cases can exceed 25%. Several predictive scores have been validated to identify at risk patient populations. These scores are driven by preexisting patient factors, comorbid conditio作者: BALE 時(shí)間: 2025-3-29 15:39 作者: 討好女人 時(shí)間: 2025-3-29 21:27 作者: 褲子 時(shí)間: 2025-3-30 02:42 作者: stress-test 時(shí)間: 2025-3-30 06:15
978-3-030-57941-8Springer Nature Switzerland AG 2021作者: 反話 時(shí)間: 2025-3-30 11:06
Christine WonAddresses complex sleep breathing disorders.Provides concrete diagnostic and treatment guidance.Case-based format geared specifically to sleep medicine specialists or trainees作者: 瑣事 時(shí)間: 2025-3-30 14:08
http://image.papertrans.cn/c/image/231535.jpg作者: ILEUM 時(shí)間: 2025-3-30 17:47 作者: 為現(xiàn)場(chǎng) 時(shí)間: 2025-3-30 21:32 作者: preservative 時(shí)間: 2025-3-31 01:36
Central Sleep Apnea and Opioid Use,tially higher response rates to bilevel and adaptive servo-ventilation. Among patients with obstructive sleep apnea, opioids appear to be a risk factor for the emergence of CSA upon treatment with CPAP.作者: WAG 時(shí)間: 2025-3-31 06:09
Obstructive and Central Sleep Apnea Treatment Challenges in Atrial Fibrillation,en shown to be a strong predictor of AF development; therefore CSA treatment is another possible risk to target in AF. Taken together, these data support the need for further consideration of early diagnosis and comprehensive management of sleep apnea in AF patients.作者: asthma 時(shí)間: 2025-3-31 09:30 作者: 能夠支付 時(shí)間: 2025-3-31 13:51
Book 2021f complicated sleep disordered breathing. It tackles complicated sleep breathing disorders by discussing their epidemiology, pathophysiology, clinical significance, physical findings, and their diagnosis and management.. . Organized into 21 chapters, opening chapters cover a variety of sleep apnea m作者: Apogee 時(shí)間: 2025-3-31 18:37 作者: LATER 時(shí)間: 2025-4-1 00:55
https://doi.org/10.1007/978-3-642-55434-6 management of patients post-stroke. A case of a patient with both obstructive and central sleep apnea after a stroke is reviewed as an example of the complexities of management in this patient population.作者: HEW 時(shí)間: 2025-4-1 03:18
Staff Participation in the Public Services pulmonary hypertension could be more severe in the presence of chronic lung disease, heart failure, and obesity hypoventilation. Studies, mostly observational, suggest that the treatment of OSA improves pulmonary hypertension.作者: ATOPY 時(shí)間: 2025-4-1 09:04
Sleep Apnea and Stroke, management of patients post-stroke. A case of a patient with both obstructive and central sleep apnea after a stroke is reviewed as an example of the complexities of management in this patient population.作者: 演講 時(shí)間: 2025-4-1 13:39
Pulmonary Hypertension in Obstructive Sleep Apnea, pulmonary hypertension could be more severe in the presence of chronic lung disease, heart failure, and obesity hypoventilation. Studies, mostly observational, suggest that the treatment of OSA improves pulmonary hypertension.
